High-speed spinning-disk interferometry on the BioCD for human diagnostic applications

Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009

Volumn , Issue , 2009, Pages 6368-6371

  Nolte, David D ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BIOASSAY; DIAGNOSIS; ECONOMIC AND SOCIAL EFFECTS; INTERFEROMETRY; MULTIPLEXING; PROTEINS;

DIAGNOSTIC APPLICATIONS; HIGH SPEED SPINNINGS; HIGH-FREQUENCY SAMPLING; HIGH-SPEED SPINNING; LIMIT OF DETECTION; OPTICAL BIO-SENSORS; PROSTATE SPECIFIC ANTIGEN; SCALING PROPERTIES;

ANTIGENS;

EID: 77950965856     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2009.5333254     Document Type: Conference Paper

References (33)

1. M. M. Varma, H. D. Inerowicz, F. E. Regnier, and D. D. Nolte, "High-speed label-free detection by spinning-disk microinterferometry, " Biosensors & Bioelectronics, vol.19, pp. 1371-1376, 2004.
2. M. Zhao, L. L. Peng, W. Cho, F. Regnier, and D. D. Nolte, "Phase-contrast BioCD: High-speed immunoassays at sub-picogram detection levels," Nanobiophotonics and Biomedical Applications III, vol.6095, pp. L950-L950, 2006.
3. X. Wang, M. Zhao, and D. D. Nolte, "Common-Path Interferometric Detection of Protein on the BioCD," Appl. Opt., vol.46, pp. 7836-7849, 2007.
4. S. A. Soper, K. Brown, A. Ellington, B. Frazier, G. Garcia-Manero, V. Gau, S. I. Gutman, D. F. Hayes, B. Korte, J. L. Landers, D. Larson, F. Ligler, A. Majumdar, M. Mascini, D. Nolte, Z. Rosenzweig, J. Wang, and D. Wilson, "Point-of-care biosensor systems for cancer diagnostics/prognostics," Biosensors & Bioelectronics, vol.21, pp. 1932-1942, 2006.
5. M. Varma, "BioCD: Self-referencing interferometer for bioesensing," in Physics, vol.PhD. West lafayette: Purdue University, 2005, pp. 114.
6. M. M. Varma, D. D. Nolte, H. D. Inerowicz, and F. E. Regnier, "Spinning-disk self-referencing interferometry of antigen-antibody recognition," Optics Letters, vol.29, pp. 950-952, 2004.
7. L. Peng, M. Varma, H. D. Inerowicz, F. E. Regnier, and D. D. Nolte, "Adaptive Optical BioCD for Biosensing," Appl. Phys. Lett., vol.86, pp. 183902-1-3, 2005.
8. L. Peng, M. M. Varma, W. Cho, F. E. Regnier, and D. D. Nolte, "Adaptive interferometry of protein on a BioCD," Appl. Opt., vol.46, pp. 5384-5395, 2007.
9. D. D. Nolte, "Semi-insulating semiconductor heterostructures: Optoelectronic properties and applications," J. Appl. Phys., vol.85, pp. 6259, 1999.
10. D. D. Nolte, T. Cubel, L. J. Pyrak-Nolte, and M. R. Melloch, "Adaptive Beam Combining and Interferometry using Photorefractive Quantum Wells," J. Opt. Soc. Am. B, vol.18, pp. 195-205, 2001.
11. M. Zhao, W. Cho, F. Regnier, and D. Nolte, "Differential phase-contrast BioCD biosensor," Appl. Opt., vol.46, pp. 6196-6209, 2007.
12. M. Zhao, X. F. Wang, and D. Nolte, "The in-line-quadrature BioCD," Nanoscale Imaging, Spectroscopy, Sensing, and Actuation for Biomedical Applications IV, vol.6447, pp. B4470-B4470, 2007.
13. H. Ozen and S. Sozen, "PSA Isoforms in prostate cancer detection," Eur. Urol. Suppl., vol.5, pp. 495, 2006.
14. S. P. Balk, Y.-J. Ko, and G. J. Bubley, "Biology of Prostate-specific antigen," J. Clin. Onc., vol.21, pp. 383-391, 2003.
15. M. C. Wang, L. D. Papsidero, M. Kuriyama, and e. al., "Prostate antigen: A new potential marker for prostatic cancer," Prostate, vol.2, pp. 89-96, 1981.
16. J. Lovgren, C. Valtonen-Andre, K. Marsal, and e. al., "Measurement of prostate-specific antigen and juman glandular kallikrein 2 in different body fluids," J. Androl., vol.20, pp. 348-355, 1999.
17. M. K. Brawer, M. A. Rennels, and R. B. Nagle, "Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy," Am. J. Clin. Path., vol.92, pp. 760-764, 1989.
18. D. G. Bostwick, "Prostate-specific antigen: Current role in diagnostic pathology of prostate cancer," Am. J. Clin. Path., vol.102, pp. S31-S37, 1994.
19. A. Lundwall and H. Lilja, "Molecular cloning of human prostate specific antigen cDNA," FEBS Letters, vol.214, pp. 317-322, 1987.
20. A. Kumar, S. D. Mikolajczyk, A. S. Goel, and e. al., "Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2," Cancer Res., vol.57, pp. 3111-3114, 1997.
21. T. K. Takayama, K. Fujikawa, and E. W. Davie, "Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.," J. Biol. Chem., vol.272, pp. 21582-21588, 1997.
22. J. Lovgren, K. Rajakoski, M. Karp, and e. al., "Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2," Biochem. Biophys. Res. Commun., vol.238, pp. 549-555, 1997.
23. S. D. Mikolajczyk, L. S. Miller, and T. J. Wang, "BPSA, a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasial.," Urology, vol.55, pp. 41-45, 2000.
24. S. D. Mikolajczyk, K. M. Marker, and L. S. Millar, "A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer," Cancer Res., vol.61, pp. 6958-6963, 2001.
25. S. D. Mikolajczyk, L. S. Grauer, and L. S. Millar, "A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum.," Urology, vol.50, pp. 710-714, 1997.
26. S. D. Mikolajczyk, L. S. Millar, and T. J. Wang, "A precursor form of prostate-specific antigen is more highly elevated in protate cancer compared with benign transition zone prostate tissue.," Cancer Res, vol.60, pp. 756-759, 2000.
27. C. Stephan, K. Jung, M. Lein, and e. al., "Molecular forms of prostatespecific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer," Cancer Epidemiol. Biomarkers Prev., vol.9, pp. 1133-1147, 2000.
28. H. Lilja, A. Christensson, and U. Dahlen, "Prostate-specific antigen in serum occur predominantly in complex with ACT," Clin. Chem., vol.37, pp. 1618-1625, 1991.
29. U. H. Stenman, J. Leinonen, and H. Alfthan, "A complex between prostate-specific antigen and ACT is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer.," Cancer Res., vol.51, pp. 222-226, 1991.
30. W. J. Catalona, J. P. Richie, and F. R. Ahmann, "Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men.," J. Urol., vol.151, pp. 1283-1290, 1994.
31. U. H. Stenman, M. Hakama, and P. Knekt, "Serum concentrations of prostate specific antigen and its complex with ACT before diagnosis of prostate cancer.," Lancet, vol.344, pp. 1594-1598, 1994.
32. F. H. Schroder, "Prostate cancer detection at low prostate specific antigen," J. Urol., vol.163, pp. 806-812, 2000.
33. X. F. Wang, M. Zhao, and D. D. Nolte, "Prostate-specific antigen immunoassays on the BioCD," Analytical And Bioanalytical Chemistry, vol.393, pp. 1151-1156, 2009.